Investment Rating - The report maintains a "Recommended" rating for the company [4] Core Views - The company reported a Q3 2025 revenue of 342 million yuan, a year-on-year increase of 16.7%, while the net profit attributable to shareholders was 79 million yuan, a decrease of 2.89% year-on-year [1] - The sales of mosquito repellent products showed significant growth, driven by consumer demand due to the chikungunya virus, with Q3 revenue reaching 132 million yuan, up 48.54% year-on-year [2] - The company is actively expanding its youth skincare product line, which is expected to become a new growth driver [3] Financial Performance - The overall gross margin for Q3 2025 was 58.96%, an increase of 1.39 percentage points year-on-year [3] - The company’s net profit margin for Q3 2025 was 22.93%, a decrease of 4.62 percentage points year-on-year [3] - The projected net profits for 2025, 2026, and 2027 are 324 million, 398 million, and 491 million yuan, respectively, with year-on-year growth rates of 7.8%, 22.9%, and 23.4% [4][5] Business Segments - In Q3 2025, the mosquito repellent segment accounted for 41.25% of total revenue, while the baby care segment contributed 45.05%, and essential oils made up 13.25% [2] - The average selling price of mosquito repellent products increased by 12.04% year-on-year to 6.14 yuan, attributed to product structure optimization [2] - The company is focusing on enhancing its marketing efforts for youth skincare products and new sunscreen lines [3]